Acutus Medical, Inc. (AFIB)

NASDAQ: AFIB · Delayed Price · USD
2.53
-0.13 (-4.89%)
At close: Jan 18, 2022 4:00 PM
2.51
-0.02 (-0.79%)
Pre-market:Jan 19, 2022 6:05 AM EST
Market Cap70.72M
Revenue (ttm)15.48M
Net Income (ttm)-115.82M
Shares Out27.95M
EPS (ttm)-4.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume261,541
Open2.65
Previous Close2.66
Day's Range2.51 - 2.68
52-Week Range2.51 - 29.95
Betan/a
AnalystsBuy
Price Target8.00 (+216.2%)
Earnings DateNov 11, 2021

About AFIB

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is based i...

IndustryMedical Devices
IPO DateAug 6, 2020
Employees291
Stock ExchangeNASDAQ
Ticker SymbolAFIB
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for Acutus Medical stock is "Buy." The 12-month stock price forecast is 8.00, which is an increase of 216.21% from the latest price.

Price Target
$8.00
(216.21% upside)
Analyst Consensus: Buy

News

Acutus Medical Announces Restructuring and Preliminary, Unaudited Fourth Quarter and Full Year 2021 Revenue

CARLSBAD, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are...

3 hours ago - GlobeNewsWire

Acutus Medical's Pulsed Field Ablation System To Be Featured During 27th Annual AF Symposium

CARLSBAD, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tr...

6 days ago - GlobeNewsWire

A Duo of Net Current Asset Value Stocks to Consider

There are some investors who buy U.S.-listed stocks that are trading below their liquidation values because they believe they can gain a lot from these stocks after the market has reappraised the share ...

Other symbols:CANG
6 days ago - GuruFocus

Recap: Acutus Medical Q3 Earnings

Acutus Medical (NASDAQ:AFIB) reported its Q3 earnings results on Thursday, November 11, 2021 at 04:01 PM. Here's what investors need to know about the announcement.

2 months ago - Benzinga

Acutus Medical Initiates CE Mark Study for Focal Pulsed Field Ablation Therapy to Treat Atrial Fibrillation

Acutus' Catheter-Based Therapy Platform, AcQBlate Force, Will Integrate Multiple Ablation Modalities Guided by Novel Noncontact Mapping Technology to Treat Complex Atrial Arrhythmias Acutus' Catheter-Ba...

2 months ago - GlobeNewsWire

Acutus Medical Reports Third Quarter 2021 Financial Results

CARLSBAD, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are...

2 months ago - GlobeNewsWire

Analysts Estimate Acutus Medical, Inc. (AFIB) to Report a Decline in Earnings: What to Look Out for

Acutus Medical, Inc. (AFIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Acutus Medical to Announce Third Quarter 2021 Financial Results

CARLSBAD, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tr...

2 months ago - GlobeNewsWire

Acutus Medical, Inc. (AFIB) Moves 9.6% Higher: Will This Strength Last?

Acutus Medical, Inc. (AFIB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength d...

3 months ago - Zacks Investment Research

Acutus Medical, Inc. (AFIB) Reports Q2 Loss, Tops Revenue Estimates

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 11.00% and 1.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Acutus Medical Appoints Niamh Pellegrini to Board of Directors

CARLSBAD, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated,...

5 months ago - GlobeNewsWire

Acutus Medical Reports Second Quarter 2021 Financial Results

CARLSBAD, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are...

5 months ago - GlobeNewsWire

Acutus Medical to Participate at the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

CARLSBAD, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tr...

5 months ago - GlobeNewsWire

Acutus Medical to Announce Second Quarter 2021 Financial Results

CARLSBAD, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tr...

5 months ago - GlobeNewsWire

AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias

MOUNTAIN VIEW, Calif., July 27, 2021 /PRNewswire/ -- AliveCor, Inc. ("AliveCor"), a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and services, and Acutus Medical ("Acutus...

5 months ago - PRNewsWire

Acutus Medical, Inc. Announces Full Exercise of Underwriter's Option to Purchase Additional Shares

CARLSBAD, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Nasdaq: AFIB) (“Acutus”) today announced that the underwriter of its previously announced public offering, which closed on July ...

5 months ago - GlobeNewsWire

Acutus Medical, Inc. Announces Pricing of Public Offering of Common Stock

CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Nasdaq: AFIB) (“Acutus”) today announced the pricing of its underwritten public offering of 5,500,000 shares of its common stock...

6 months ago - GlobeNewsWire

Acutus Medical, Inc. Announces Proposed Public Offering of Common Stock

CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today announced it has commenced an underwritten public offering of 5,500,000 shares o...

6 months ago - GlobeNewsWire

Acutus Medical Reports Preliminary Unaudited Second Quarter 2021 Financial Results

CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are...

6 months ago - GlobeNewsWire

Acutus Medical Receives Green Signal From FDA To Start AcQBlate Atrial Fibrillation Trial

The FDA has signed off Investigational Device Exemption (IDE) AcQBlate AF trial for Acutus Medical Inc's (NASDAQ: AFIB) AcQBlate Force Sensing Ablation Catheter and System. The trial is expected to enro...

7 months ago - Benzinga

Acutus Medical Receives FDA Approval to Initiate US Atrial Fibrillation IDE Trial with the AcQBlate® FORCE Sensing Ab...

CARLSBAD, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today annou...

7 months ago - GlobeNewsWire

Acutus Medical to Present at the 41st Annual William Blair Growth Stock Conference

CARLSBAD, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tre...

7 months ago - GlobeNewsWire

Acutus Medical Reports First Quarter 2021 Financial Results

CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

8 months ago - GlobeNewsWire

Acutus Medical to Announce First Quarter 2021 Financial Results

CARLSBAD, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and t...

8 months ago - GlobeNewsWire

Acutus Medical to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and t...

8 months ago - GlobeNewsWire